These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31971597)

  • 1. Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    Stray K; Perron M; Porter DP; Anderson F; Lewis SA; Perry J; Miller M; Cihlar T; DeVincenzo J; Chien JW; Jordan R
    J Infect Dis; 2020 Oct; 222(9):1468-1477. PubMed ID: 31971597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus.
    Porter DP; Guo Y; Perry J; Gossage DL; Watkins TR; Chien JW; Jordan R
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32071058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
    Marty FM; Chemaly RF; Mullane KM; Lee DG; Hirsch HH; Small CB; Bergeron A; Shoham S; Ljungman P; Waghmare A; Blanchard E; Kim YJ; McKevitt M; Porter DP; Jordan R; Guo Y; German P; Boeckh M; Watkins TR; Chien JW; Dadwal SS
    Clin Infect Dis; 2020 Dec; 71(11):2787-2795. PubMed ID: 31915807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.
    Gottlieb J; Torres F; Haddad T; Dhillon G; Dilling DF; Knoop C; Rampolla R; Walia R; Ahya V; Kessler R; Budev M; Neurohr C; Glanville AR; Jordan R; Porter D; McKevitt M; German P; Guo Y; Chien JW; Watkins TR; Zamora MR
    J Heart Lung Transplant; 2023 Jul; 42(7):908-916. PubMed ID: 36964084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
    Chemaly RF; Dadwal SS; Bergeron A; Ljungman P; Kim YJ; Cheng GS; Pipavath SN; Limaye AP; Blanchard E; Winston DJ; Stiff PJ; Zuckerman T; Lachance S; Rahav G; Small CB; Mullane KM; Patron RL; Lee DG; Hirsch HH; Waghmare A; McKevitt M; Jordan R; Guo Y; German P; Porter DP; Gossage DL; Watkins TR; Marty FM; Chien JW; Boeckh M
    Clin Infect Dis; 2020 Dec; 71(11):2777-2786. PubMed ID: 31793991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein.
    DeVincenzo J; Tait D; Efthimiou J; Mori J; Kim YI; Thomas E; Wilson L; Harland R; Mathews N; Cockerill S; Powell K; Littler E
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study.
    DeVincenzo JP; McClure MW; Symons JA; Fathi H; Westland C; Chanda S; Lambkin-Williams R; Smith P; Zhang Q; Beigelman L; Blatt LM; Fry J
    N Engl J Med; 2015 Nov; 373(21):2048-58. PubMed ID: 26580997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis.
    Oliveira DB; Iwane MK; Prill MM; Weinberg GA; Williams JV; Griffin MR; Szilagyi PG; Edwards KM; Staat MA; Hall CB; Durigon EL; Erdman DD
    J Clin Virol; 2015 Apr; 65():26-31. PubMed ID: 25766983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
    Cunningham S; Piedra PA; Martinon-Torres F; Szymanski H; Brackeva B; Dombrecht E; Detalle L; Fleurinck C;
    Lancet Respir Med; 2021 Jan; 9(1):21-32. PubMed ID: 33002427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral GS-5806 activity in a respiratory syncytial virus challenge study.
    DeVincenzo JP; Whitley RJ; Mackman RL; Scaglioni-Weinlich C; Harrison L; Farrell E; McBride S; Lambkin-Williams R; Jordan R; Xin Y; Ramanathan S; O'Riordan T; Lewis SA; Li X; Toback SL; Lin SL; Chien JW
    N Engl J Med; 2014 Aug; 371(8):711-22. PubMed ID: 25140957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
    Tang W; Li Y; Song Q; Wang Z; Li M; Zhang Q; Wang Y; Ye W; Li Y
    J Virol; 2021 Sep; 95(20):e0120521. PubMed ID: 34379500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.
    Ahmad A; Eze K; Noulin N; Horvathova V; Murray B; Baillet M; Grey L; Mori J; Adda N
    N Engl J Med; 2022 Feb; 386(7):655-666. PubMed ID: 35172056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of respiratory syncytial virus fusion protein from clinical isolates of Korean children in palivizumab era, 2009-2015.
    Choi SH; Park KS; Kim YJ
    J Infect Chemother; 2019 Jul; 25(7):514-519. PubMed ID: 30885457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of fusion inhibitor treatment of RSV in African green monkeys.
    González-Parra G; Dobrovolny HM
    J Theor Biol; 2018 Nov; 456():62-73. PubMed ID: 30048719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
    Kim YI; Pareek R; Murphy R; Harrison L; Farrell E; Cook R; DeVincenzo J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):525-530. PubMed ID: 28990339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection.
    German P; Xin Y; Chien JW; Weng W; Mackman R; Lewis SA; Meng A; Ling J; Mathias A
    J Clin Pharmacol; 2018 Aug; 58(8):1025-1034. PubMed ID: 29663420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus.
    Ferrero F; Lin CY; Liese J; Luz K; Stoeva T; Nemeth A; Gijón M; Calvo C; Natalini S; Toh TH; Deleu S; Chen B; Rusch S; Sánchez BL; Leipoldt I; Vijgen L; Huntjens D; Baguet T; Bertzos K; Gamil M; Stevens M;
    Paediatr Drugs; 2024 Jul; 26(4):411-427. PubMed ID: 38649595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.